title: Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
abstract: The pharmacological properties of unfractionated dermatan sulfate (U-DS, mean MW 25 kd, range 12-45 kd) of a low molecular weight fraction (LMW-DS, mean MW 4 kd range 1.6-8 kd), and of 2 oversulfated derivatives (S-DS1 and S-DS2, 2 and 3.8 sulfate groups per disaccharide units) were investigated. In a purified system, LMW-DS, S-DS1 and S-DS2 were respectively 0.5, 10 and 17 times more potent than U-DS to catalyse thrombin inhibition by heparin cofactor II. Identical differences were observed for the respective anticoagulant activities (activated partial thromboplastin time and thrombin clotting time). After bolus IV injection of increasing doses the pharmacokinetic parameters of U-DS were slightly dose dependent, and the total clearance of LMW-DS was, on the average, 2 times higher. The patterns of disappearance of S-DS1 and S-DS2 were strongly dose dependent and became concave-convex, suggesting different mechanisms of clearance. After SC injection, the bioavailability was less than 50% for U-DS and at least 100% for LMW-DS. The antithrombotic activity (Wessler-thromboplastin model) of LMW-DS was 2 timer lower than that of U-DS. In contrast to their in vitro (and ex vivo) enhanced anticoagulant activities, the antithrombotic potency of S-DS1 was identical to that of U-DS, while, at the same doses S-DS2 was devoid of any activity.
authors: Laboratoire d'Hemostase, Centre de Transfusion, Toulouse, France.
authors: F
authors: F
authors: Dol
authors: M
authors: M
authors: Petitou
authors: J
authors: J
authors: Choay
authors: P
authors: P
authors: Sie
authors: G
authors: G
authors: Houin
authors: B
authors: B
authors: Boneu
mesh_terms: D000818:Animals; D000925:Anticoagulants; D002807:Chondroitin / Q000031:analogs & derivatives*; D003871:Dermatan Sulfate / Q000493:pharmacokinetics / Q000494:pharmacology*; D005343:Fibrinolytic Agents; D008970:Molecular Weight; D011817:Rabbits; D013329:Structure-Activity Relationship; D013431:Sulfates; D013917:Thrombin / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D013431:Sulfates; D003871:Dermatan Sulfate; D002807:Chondroitin; D013917:Thrombin